MWNA
TMO icon

Marshall Wace North America’s Thermo Fisher Scientific TMO Stock Holding History

Marshall Wace North America’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$551M Sell
963,909
-49,797
-5% -$27.3M 2.35% 6
2021
Q2 		$511M Buy
1,013,706
+286,186
+39% +$135M 2.13% 6
2021
Q1 		$332M Sell
727,520
-83,070
-10% -$39.6M 1.37% 8
2020
Q4 		$378M Buy
810,590
+509,875
+170% +$239M 1.7% 6
2020
Q3 		$133M Sell
300,715
-67,957
-18% -$28.1M 0.85% 22
2020
Q2 		$134M Sell
368,672
-111,700
-23% -$37.4M 0.88% 21
2020
Q1 		$136M Sell
480,372
-285,987
-37% -$90.2M 1.03% 15
2019
Q4 		$249M Buy
766,359
+40,811
+6% +$12.4M 1.2% 15
2019
Q3 		$211M Buy
725,548
+250,602
+53% +$71.8M 1.2% 13
2019
Q2 		$139M Buy
474,946
+166,927
+54% +$46M 0.87% 27
2019
Q1 		$84.3M Buy
308,019
+294,820
+2,234% +$73.4M 0.6% 46
2018
Q4 		$2.95M Buy
+13,199
New +$3.1M 0.03% 355
2017
Q2 		– Sell
-231,025
Closed -$35.6M – 1461
2017
Q1 		$35.6M Buy
+231,025
New +$35.3M 0.28% 101
2013
Q4 		– Sell
-208,206
Closed -$19.2M – 836
2013
Q3 		$19.2M Buy
208,206
+97,051
+87% +$8.78M 0.59% 39
2013
Q2 		$9.41M Buy
+111,155
New +$9.25M 0.74% 38

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace North America's TMO Position: Q3 2021 in Review

Marshall Wace North America reduced its Thermo Fisher Scientific (TMO) stake by 4.9% in Q3 2021, selling an estimated $27.3M and leaving 963,909 shares worth $551M. The position accounts for 2.35% of the portfolio, ranked #6.

Marshall Wace North America first reported a position in TMO in Q2 2013 and has held it in 15 quarters since. 2,131 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Marshall Wace North America held 963,909 shares of Thermo Fisher Scientific worth $551M as of Q3 2021.
  • Marshall Wace North America sold 49,797 Thermo Fisher Scientific shares in Q3 2021, an estimated $27.3M.
  • Thermo Fisher Scientific made up 2.35% of Marshall Wace North America's portfolio in Q3 2021, its #6 holding.
  • Marshall Wace North America first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 15 quarters since.
  • 2,131 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.